A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Non-muscle-invasive Bladder Cancer · NMIBC · Non-Muscle Invasive Bladder Carcinoma · Non-Muscle Invasive Bladder Neoplasms · Non-Muscle Invasive Bladder Urothelial Carcinoma · Urothelial Carcinoma Bladder

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Arkansas Urology, Little Rock, Arkansas, United States

  • Tower Urology, Los Angeles, California, United States

    Contact: Study coordinator (Terry Williams) · williamst@towerurology.com · 310-854-9898
    Contact: Principal Investigator (David Josephson)
  • Saint John's Cancer Institute, Santa Monica, California, United States

    Contact: Study coordinator (Frances Feng) · frances.feng@providence.org
  • Montefiore Medical Center, The Bronx, New York, United States

    Contact: Study coordinator (Jerel Johnson) · jerjohnson@montefiore.org
  • Carolina Urologic Research Center, Myrtle Beach, South Carolina, United States

    Contact: Study coordinator (Jessica Richardson) · jrichardson@curcmb.com
  • Urology Associates, P.C., Nashville, Tennessee, United States

  • Urology Clinics of North Texas, Dallas, Texas, United States

    Contact: Study coordinator (Holly Baril) · hbaril@urologyclinics.com · 214-658-1987
  • Baylor College of Medicine, Houston, Texas, United States

    Contact: Study coordinator (Sharon Harrison) · sharons@bcm.edu
  • The University of Texas San Antonio, San Antonio, Texas, United States

    Contact: Study coordinator (Ahmad Abdel-Aziz) · Abdelaziza1@uthscsa.edu
  • Urology San Antonio/USA Clinical Trials, San Antonio, Texas, United States

    Contact: Study coordinator (Stefanie Galvin) · stefanie.galvin@usa-clinicaltrials.com
  • The Urology Place, San Antonio, Texas, United States

    Contact: Study coordinator (Olivia Soto) · olivia@theupi.com · 210-617-3670
  • Westmead Private Hospital, Westmead, New South Wales, Australia

    Contact: Study coordinator (Dana Chatfield) · ChatfieldD@ramsayhealth.com.au · +61 4 1943 4636
    Contact: Principal Investigator (Manish Patel)
  • Austin Health, Heidelberg, Victoria, Australia

    Contact: Study coordinator (Robyn Bolger) · Robyn.Bolger@austin.org.au · +61 3 9496 4915
    Contact: Principal Investigator (Joseph Ischia)
  • Warringal Private Hospital, Heidelberg, Victoria, Australia

    Contact: Study coordinator (Zahra Thompson) · ThompsonZ@ramsayhealth.com.au · +61 456 359 569
    Contact: Principal Investigator (Damien Bolton)
  • Penninsula Private Hospital, Langwarrin, Victoria, Australia

    Contact: Study coordinator (David McArdle) · McArdleD@ramsayhealth.com.au · +61 3 9788 3647
    Contact: Principal Investigator (George Koufogiannis)
  • The Royal Melbourne Hospital, Parkville, Victoria, Australia

    Contact: Study coordinator (Avanthika Lakshmanan) · Avanthika.Lakshmanan@mh.org.au · +61 3 9342 7294
    Contact: Principal Investigator (Paul Anderson)
  • Hollywood Private Hospital, Nedlands, Western Australia, Australia

    Contact: Study coordinator (Eilish McCarthy) · McCarthyEilish@ramsayhealth.com.au · +61 8 9346 6022
    Contact: Principal Investigator (Tom Shannon)
מובילי המחקר
  • Medical Monitor

    Study Director

    Aura Biosciences